Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 Study
Clinical trial NCT04936113 · TERMINATED
Trial details
- NCT number
- NCT04936113
- Sponsor
- Forte Biosciences, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-02
- Primary completion
- 2021-09-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.